Cerus (CERS) Total Debt Growth (5y) (2015 - 2026)
Cerus (CERS) Total Debt Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.62% |
| Dec 31, 2025 | 11.76% |
| Sep 30, 2025 | 13.78% |
| Mar 31, 2025 | 13.93% |
| Dec 31, 2024 | 13.63% |
| Sep 30, 2024 | 13.45% |
| Jun 30, 2024 | 13.80% |
| Mar 31, 2024 | 16.59% |
| Dec 31, 2023 | 21.72% |
| Sep 30, 2023 | 21.35% |
| Jun 30, 2023 | 19.06% |
| Mar 31, 2023 | 19.56% |
| Dec 31, 2022 | 18.56% |
| Sep 30, 2022 | 18.55% |
| Jun 30, 2022 | 31.91% |
| Mar 31, 2022 | 30.90% |
| Dec 31, 2021 | 29.08% |
| Sep 30, 2021 | 27.29% |
| Jun 30, 2021 | 26.38% |
| Mar 31, 2021 | 26.63% |